Next Article in Journal

The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers

Next Article in Special Issue

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

Previous Article in Journal

Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy

Previous Article in Special Issue

Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Cancers 2023, 15(8), 2373; https://doi.org/10.3390/cancers15082373

Action	Date	Notes	Link
article xml file uploaded	19 April 2023 12:07 CEST	Original file	-
article xml uploaded.	19 April 2023 12:07 CEST	Update	-
article pdf uploaded.	19 April 2023 12:07 CEST	Version of Record	https://www.mdpi.com/2072-6694/15/8/2373/pdf-vor
article supplementary file uploaded.	19 April 2023 12:07 CEST	-	https://www.mdpi.com/2072-6694/15/8/2373#supplementary
article html file updated	19 April 2023 12:08 CEST	Original file	-
article xml file uploaded	26 April 2023 06:33 CEST	Update	-
article xml uploaded.	26 April 2023 06:33 CEST	Update	https://www.mdpi.com/2072-6694/15/8/2373/xml
article pdf uploaded.	26 April 2023 06:33 CEST	Updated version of record	https://www.mdpi.com/2072-6694/15/8/2373/pdf
article html file updated	26 April 2023 06:35 CEST	Update	https://www.mdpi.com/2072-6694/15/8/2373/html

Back to TopTop